Center for Sarcoma and Connective Tissue Oncology

Overview

The Center for Sarcoma and Connective Tissue Oncology at Massachusetts General Hospital Cancer Center specializes in the diagnosis and treatment of bone and soft tissue tumors, both malignant and benign. The team represents one of the largest sarcoma treatment groups in the country.

We offer comprehensive, multidisciplinary care for patients with:

• Soft Tissue Sarcomas
• Desmoid Fibromatosis
• Gastrointestinal Stromal Tumor (GIST)
• Giant Cell Tumor of Bone
• Malignant Peripheral Nerve Sheath Tumor (MPNST)
• Bone Cancer (Osteosarcoma)
• Chordoma

Our patients also have access to The Harris Center for Chordoma Care, a specialized program at the Cancer Center dedicated to chordoma research and care.

Multidisciplinary Patient Care

Because the treatment of these cancers is complex, highly specialized experts are needed to guarantee the best possible outcomes. Each patient in our program is cared for by a multidisciplinary team of experts who specialize in the diagnosis and treatment of sarcomas and connective tissue cancers. Each patient’s medical team works together throughout care and follow-up, ensuring a seamless continuity of care.

Research

The Sarcoma/Oncology Computational Biology Laboratory conducts cancer genomic/bioinformatics studies in order to detect molecular patterns relevant to tumor outcome and response to conventional or novel treatments.